Young Turks: Here are four startups which can be serving to in battle in opposition to COVID


India’s startup ecosystem has joined the combat in opposition to COVID-19 as entrepreneurs, buyers and startups come collectively to supply funds, help and sources because the nation gasps for breath.

Epigamia together with Sauce.vc is working a fundraiser to help the collective – ‘Doctors For You’. The funds will probably be used to obtain essential medical tools, arrange COVID care centres and on board healthcare personnel for help at these centres.

A bunch of IIT Kanpur alumni have launched the ‘Breathe India’ fundraiser. This neighborhood is working with the save Life Foundation to obtain oxygen concentrators for Delhi. It additionally goals to lend help to communities in rural India. Along with the suitable stroll basis, the initiative will elevate funds to provide oxygen concentrators and different lifesaving tools and medicines to Uttar Pradesh.

Crowdfunding platform Milaap is at present working over 15,400 campaigns to boost funds for COVID aid. As of May 6 these fundraisers to provide hospital necessities, concentrators and different medical provides have raised Rs 152 crore. Organisations reminiscent of Swasth, Act Grants, Shahrukh Khan’s Meer Foundation, Ola, Uber, Swiggy and Zomato are at present working campaigns on the platform.

In the final week version – CNBC-TV18 introduced the story of Mission Oxygen that has been working to import oxygen concentrators into India. The group took a recent supply of 800 oxygen concentrators on May 5 with extra to observe and has began distributing these to hospitals and healthcare services throughout Delhi-NCR.

They have additionally began work on an oxygen plant on the Deen Dayal Upadhya Hospital.

In this particular version of Young Turks, Shereen Bhan spoke to Rohan Mirchandani, co-founder of Epigamia,  Mayukh Choudhury, CEO & Co-Founder of Milaap.org, Ashutosh Ranka of Breathe India and Rahul Aggarwal of Mission Oxygen.

Watch accompanying video for extra.



LEAVE A REPLY

Please enter your comment!
Please enter your name here